BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24

• Press Releases

  Sunshine Guojian Releases 2026 Interim Report:

  August 21, 2026

   · 

  8 min read
• Press Releases

  Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline

  August 21, 2026

   · 

  6 min read
• Press Releases

  Bavarian Nordic to Launch New Share Buy-back Program of up to DKK 750 Million

  August 21, 2026

   · 

  3 min read
• Press Releases

  Bavarian Nordic Reports Strong First Half 2026 Results

  August 21, 2026

   · 

  5 min read
• Press Releases

  Bavarian Nordic Upgrades its Full-Year 2026 Financial Guidance

  August 21, 2026

   · 

  3 min read
• Press Releases

  Akeso’s AK157D1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline

  August 21, 2026

   · 

  5 min read
• Press Releases

  3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth

  August 21, 2026

   · 

  10 min read
• Press Releases

  Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026

  August 21, 2026

   · 

  5 min read
• Press Releases

  European Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) plus daratumumab for relapsed/refractory multiple myeloma, offering a potential new standard of care

  August 21, 2026

   · 

  18 min read
• Press Releases

  Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World’s First Approved 4-1BB-Targeting Therapy

  August 21, 2026

   · 

  7 min read